Designing Preclinical Studies That Drive Decisions — Not Just More Data
Kate Green
By Ted Barrett, PhD – Senior Director, Pharmacology In biotech, teams often equate the accumulation of preclinical experiments, endpoints, and validation work with progress. That instinct makes sense, especially in a field rooted in scientific rigor. But in today’s capital-constrained environment, that mindset is shifting. The question is no longer how much preclinical data can be generated, but whether that ... Read More The post Designing Preclinical Studies That Drive Decisions — Not Just Mor